The Chinese Stroke Association scientific statement: intravenous thrombolysis in acute ischaemic stroke

The most effective medical treatment for acute ischaemic stroke (AIS) is to offer intravenous thrombolysis during the ultra-early period of time after the onset. Even based on the Consensus of Chinese Experts on Intravenous Thrombolysis for AIS in 2012 and 2014 Chinese Guidelines on the Diagnosis an...

Descripción completa

Detalles Bibliográficos
Autores principales: Dong, Qiang, Dong, Yi, Liu, Liping, Xu, Anding, Zhang, Yusheng, Zheng, Huaguang, Wang, Yongjun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Stroke & Vascular Neurology 2017
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5628383/
https://www.ncbi.nlm.nih.gov/pubmed/28989804
http://dx.doi.org/10.1136/svn-2017-000074
_version_ 1783268873911402496
author Dong, Qiang
Dong, Yi
Liu, Liping
Xu, Anding
Zhang, Yusheng
Zheng, Huaguang
Wang, Yongjun
author_facet Dong, Qiang
Dong, Yi
Liu, Liping
Xu, Anding
Zhang, Yusheng
Zheng, Huaguang
Wang, Yongjun
author_sort Dong, Qiang
collection PubMed
description The most effective medical treatment for acute ischaemic stroke (AIS) is to offer intravenous thrombolysis during the ultra-early period of time after the onset. Even based on the Consensus of Chinese Experts on Intravenous Thrombolysis for AIS in 2012 and 2014 Chinese Guidelines on the Diagnosis and Treatment of AIS, the rate of thrombolysis for AIS in China remained around 2.4%, and the rate of intravenous tissue plasminogen activator usage was only about 1.6% in real world. The indication of thrombolysis for AIS has been expanded, and contraindications have been reduced with recently published studies. In order to facilitate the standardisation of treating AIS, improve the rate of thrombolysis and benefit patients who had a stroke, Chinese Stroke Association has organised and developed this scientific statement.
format Online
Article
Text
id pubmed-5628383
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Stroke & Vascular Neurology
record_format MEDLINE/PubMed
spelling pubmed-56283832017-10-06 The Chinese Stroke Association scientific statement: intravenous thrombolysis in acute ischaemic stroke Dong, Qiang Dong, Yi Liu, Liping Xu, Anding Zhang, Yusheng Zheng, Huaguang Wang, Yongjun Stroke Vasc Neurol Review The most effective medical treatment for acute ischaemic stroke (AIS) is to offer intravenous thrombolysis during the ultra-early period of time after the onset. Even based on the Consensus of Chinese Experts on Intravenous Thrombolysis for AIS in 2012 and 2014 Chinese Guidelines on the Diagnosis and Treatment of AIS, the rate of thrombolysis for AIS in China remained around 2.4%, and the rate of intravenous tissue plasminogen activator usage was only about 1.6% in real world. The indication of thrombolysis for AIS has been expanded, and contraindications have been reduced with recently published studies. In order to facilitate the standardisation of treating AIS, improve the rate of thrombolysis and benefit patients who had a stroke, Chinese Stroke Association has organised and developed this scientific statement. Stroke & Vascular Neurology 2017-06-02 /pmc/articles/PMC5628383/ /pubmed/28989804 http://dx.doi.org/10.1136/svn-2017-000074 Text en © Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2017. All rights reserved. No commercial use is permitted unless otherwise expressly granted. This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
spellingShingle Review
Dong, Qiang
Dong, Yi
Liu, Liping
Xu, Anding
Zhang, Yusheng
Zheng, Huaguang
Wang, Yongjun
The Chinese Stroke Association scientific statement: intravenous thrombolysis in acute ischaemic stroke
title The Chinese Stroke Association scientific statement: intravenous thrombolysis in acute ischaemic stroke
title_full The Chinese Stroke Association scientific statement: intravenous thrombolysis in acute ischaemic stroke
title_fullStr The Chinese Stroke Association scientific statement: intravenous thrombolysis in acute ischaemic stroke
title_full_unstemmed The Chinese Stroke Association scientific statement: intravenous thrombolysis in acute ischaemic stroke
title_short The Chinese Stroke Association scientific statement: intravenous thrombolysis in acute ischaemic stroke
title_sort chinese stroke association scientific statement: intravenous thrombolysis in acute ischaemic stroke
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5628383/
https://www.ncbi.nlm.nih.gov/pubmed/28989804
http://dx.doi.org/10.1136/svn-2017-000074
work_keys_str_mv AT dongqiang thechinesestrokeassociationscientificstatementintravenousthrombolysisinacuteischaemicstroke
AT dongyi thechinesestrokeassociationscientificstatementintravenousthrombolysisinacuteischaemicstroke
AT liuliping thechinesestrokeassociationscientificstatementintravenousthrombolysisinacuteischaemicstroke
AT xuanding thechinesestrokeassociationscientificstatementintravenousthrombolysisinacuteischaemicstroke
AT zhangyusheng thechinesestrokeassociationscientificstatementintravenousthrombolysisinacuteischaemicstroke
AT zhenghuaguang thechinesestrokeassociationscientificstatementintravenousthrombolysisinacuteischaemicstroke
AT wangyongjun thechinesestrokeassociationscientificstatementintravenousthrombolysisinacuteischaemicstroke
AT dongqiang chinesestrokeassociationscientificstatementintravenousthrombolysisinacuteischaemicstroke
AT dongyi chinesestrokeassociationscientificstatementintravenousthrombolysisinacuteischaemicstroke
AT liuliping chinesestrokeassociationscientificstatementintravenousthrombolysisinacuteischaemicstroke
AT xuanding chinesestrokeassociationscientificstatementintravenousthrombolysisinacuteischaemicstroke
AT zhangyusheng chinesestrokeassociationscientificstatementintravenousthrombolysisinacuteischaemicstroke
AT zhenghuaguang chinesestrokeassociationscientificstatementintravenousthrombolysisinacuteischaemicstroke
AT wangyongjun chinesestrokeassociationscientificstatementintravenousthrombolysisinacuteischaemicstroke

Ejemplares similares